BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8440191)

  • 1. The effect of leukemia inhibitory factor on bone in vivo.
    Cornish J; Callon K; King A; Edgar S; Reid IR
    Endocrinology; 1993 Mar; 132(3):1359-66. PubMed ID: 8440191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor: a novel bone-active cytokine.
    Reid LR; Lowe C; Cornish J; Skinner SJ; Hilton DJ; Willson TA; Gearing DP; Martin TJ
    Endocrinology; 1990 Mar; 126(3):1416-20. PubMed ID: 2106430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
    Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
    Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukaemia inhibitory factor and bone cell function.
    Martin TJ; Allan EH; Evely RS; Reid IR
    Ciba Found Symp; 1992; 167():141-50; discussion 150-5. PubMed ID: 1425010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
    Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
    J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia inhibitory factor enhances bone formation in calvarial bone defect.
    Dazai S; Akita S; Hirano A; Rashid MA; Naito S; Akino K; Fujii T
    J Craniofac Surg; 2000 Nov; 11(6):513-20. PubMed ID: 11314490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia inhibitory factor is mitogenic to osteoblasts.
    Cornish J; Callon KE; Edgar SG; Reid IR
    Bone; 1997 Sep; 21(3):243-7. PubMed ID: 9276089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures.
    Malaval L; Gupta AK; Aubin JE
    Endocrinology; 1995 Apr; 136(4):1411-8. PubMed ID: 7895651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
    Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE
    Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice.
    Marcelli C; Yates AJ; Mundy GR
    J Bone Miner Res; 1990 Oct; 5(10):1087-96. PubMed ID: 2080720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia inhibitory factor (LIF) binding protein attenuates the phlogistic and abolishes the chondral effects of LIF in goat joints.
    Bell M; Carroll GJ; Chapman H; Layton M; Mills J
    J Rheumatol; 1997 Dec; 24(12):2394-402. PubMed ID: 9415649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.
    Gouin F; Couillaud S; Cottrel M; Godard A; Passuti N; Heymann D
    Cytokine; 1999 Apr; 11(4):282-9. PubMed ID: 10328867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism for sympathectomy-induced bone resorption in the middle ear.
    Sherman BE; Chole RA
    Otolaryngol Head Neck Surg; 1995 Nov; 113(5):569-81. PubMed ID: 7478647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Chesnokova V; Melmed S
    Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells.
    Marusić A; Kalinowski JF; Jastrzebski S; Lorenzo JA
    J Bone Miner Res; 1993 May; 8(5):617-24. PubMed ID: 8511989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic effects of leukemia inhibitory factor on osteoblastic differentiation.
    Malaval L; Aubin JE
    J Cell Biochem Suppl; 2001; Suppl 36():63-70. PubMed ID: 11455571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interleukin-1 on bone turnover in normal mice.
    Boyce BF; Aufdemorte TB; Garrett IR; Yates AJ; Mundy GR
    Endocrinology; 1989 Sep; 125(3):1142-50. PubMed ID: 2788075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of leukemia inhibitory factor on bone resorption and DNA synthesis in neonatal mouse calvaria.
    Lowe C; Cornish J; Martin TJ; Reid IR
    Calcif Tissue Int; 1991 Dec; 49(6):394-7. PubMed ID: 1818764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia inhibitory factor (LIF) inhibits basal bone resorption in fetal rat long bone cultures.
    Lorenzo JA; Sousa SL; Leahy CL
    Cytokine; 1990 Jul; 2(4):266-71. PubMed ID: 2129503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.